Par Drugs and Chemicals Limited
Incorporated in 1982, Par Drugs & Chemicals Ltd manufactures APIs and Fine Chemicals
What Par files
- Others59
- Important29
- Board Meeting27
- Dividend/Bonus2
- Updates1
- Insider Trade1
Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
Par Drugs And Chemicals Limited announced its 27th Annual General Meeting will be held in Vadodara. The Annual Report is available via web-link and distributed electronically to shareholders with registered emails.
Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026
Par Drugs' board met. Approved FY26 annual results: Revenue ₹103.66 Cr, PAT ₹13.11 Cr. Key approvals include higher remuneration for MD, CEO (₹0.64 Cr each), & Ind. Director (₹0.24 Cr), all subject to shareholder vote. MD/CEO now authorized for investment management.
Par Drugs And Chemicals Limited has informed the Exchange regarding Appointment of M/s Maulin Shah & Associates, Cost Accountant as Cost Auditor of the Company w.e.f. April 01, 2026.